Navigation Links
Rosetta Genomics Announces Issuance of Additional U.S. Patent
Date:5/9/2011

st challenges from third parties; Rosetta's need and ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its products and services; Rosetta's ability to obtain regulatory clearances or approvals that may be required for its products and services; the ability to obtain coverage and adequate payment from health insurers for the products and services comprising Rosetta's technology; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta's Annual Report on Form 20-F for the year ended December 31, 2010 as filed with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law.Company Contact:Investor Contacts:Rosetta Genomics

Lippert/Heilshorn & AssociatesKen Berlin, President & CEO

Anne Marie Fields(215) 382-9000 ext. 326

(212) 838-3777investors@rosettagenomics.com

afields@lhai.comorBruce Voss(310) 691-7100bvoss@lhai.com
'/>"/>

SOURCE Rosetta Genomics, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
2. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
5. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
6. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
7. First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval
8. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
9. Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum
10. MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
11. Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics miRview(TM) Squamous Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today ... the second quarter ending June 30, 2015. ... organization.  We are excited to be near the completion ... conducted with topline results expected in the fourth quarter," ... Therapeutics, Inc. "Translarna is now commercially available in 12 ...
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... 30, 2015 Eisai Inc. announced today that ... United States , European Union and ... respectively) for eribulin, for the treatment of patients with ... chemotherapy for advanced or metastatic disease. ... pivotal global Phase 3 clinical trial (Study 309), which ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... SUNNYVALE, Calif., Oct. 24, 2011 Accuray Incorporated (Nasdaq: ... that it will report results for its first quarter of ... 8, 2011 after the market closes. A conference ... fiscal year 2012 will begin at 2:00 p.m. PST/5:00 p.m. ...
... Awarepoint Corporation , the leading provider of ... the hiring of four senior management executives to support ... solutions in hospitals and clinics. Merrie Wallace, R.N., B.S.N., ... solutions, reporting to Awarepoint CEO Jay Deady. Chris Cosgrove ...
Cached Medicine Technology:Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012 2Awarepoint Expands Senior Management Team 2Awarepoint Expands Senior Management Team 3
(Date:7/31/2015)... ... July 31, 2015 , ... Creating one of the most modern fertility ... a visionary image that goes beyond the boundaries of fertility medicine. , As ... extraordinary heights with dependable patient support, affordable treatments, unending hope, and high fertility success ...
(Date:7/31/2015)... ... , ... The Mount Sinai Health System will work with Columbia Care LLC, ... experimental treatments. The collaboration moves into the next phase with the recent decision by ... state licenses to produce and dispense medical marijuana. , Mount Sinai and Columbia ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently, ZKB filed ... Ohio, Western Division (Case No. 3:15-cv-00397) involving the Implanon® contraceptive implant . ... migration of their Implanon® implants, inability to locate the implants, unsuccessful and invasive ...
(Date:7/31/2015)... ... 31, 2015 , ... Florida Hospital Tampa has started treating ... for targeted delivery of fluids to selected sites in the peripheral vascular system. ... with the device that provides direct, local delivery of chemotherapy to the pancreas. ...
(Date:7/31/2015)... ... 31, 2015 , ... Awarded to only the Top 10 hair transplant practices ... are the latest recipients of the Center of Clinical Excellence for ARTAS Robotic ... leaders in the science of hair transplant. , Parsa Mohebi Hair Restoration is known ...
Breaking Medicine News(10 mins):Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2
... GENCO Supply Chain Solutions, company, to present, ... during U.S. Environmental Protection Agency,s (Region III) Pharmaceutical ... ... Capital Returns, Inc. (CRI), the,pharmaceutical industry,s leading processor of ...
... WALNUT CREEK, Calif., June 5 Longs Drug,Stores Corporation (NYSE: LDG ) today reported preliminary total retail drug,store sales for the four-week and seventeen-week periods ended ... Periods ended ... ... (4 weeks) (17 weeks), Total retail drug ...
... OSHA ,Star Site, PITTSBURGH, June 5 ... Cranberry, Pa. manufacturing plant has been designated a,national ... Occupational,Safety and Health Administration (OSHA). Fewer than 85 ... the U.S. have earned,this distinction since the VPP ...
... Closer Look at The Value of,MRIs is now ... website, http://www.msassociation.org . This three part video,features: ... first-hand,account on the experience of undergoing an MRI; ... the importance of MRIs to monitor disease,progression; and ...
... Awarded Top Juice Beverage by Health Magazine, SEATTLE, ... and,juice producers, and its Yellow Mango Orchard natural 100 ... Buys in 2008 by Health,Magazine., With the help ... products in beauty, food and fitness to the ultimate ...
... 5 Benchmarking is not a luxury;,it is an ... research,excerpt presents a survey analysis of 30 companies and ... are using benchmarking in a,difficult economy., The complete ... to benchmark, the goals of benchmarking studies, how companies ...
Cached Medicine News:Health News:Pioneering Safe Medication Return Initiative Reviewed During Pharmaceutical Disposal Summit 2Health News:Longs Reports Preliminary May Retail Drug Store Sales 2Health News:MSA Cranberry Plant Named One of Safest in Country 2Health News:MSA Cranberry Plant Named One of Safest in Country 3Health News:Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs 2Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 2Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 3Health News:Demonstrating the Value of Benchmarking in an Uncertain Economy 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: